Xenon Pharmaceuticals (XENE) Stock Forecast & Price Target

XENE price $36.75 +0.41 +1.13%

Ticker
XENE
Price
$36.75
Change
+0.41 +1.13%
Market cap ?
$3.56B
P/E ?
-7.67
Forward P/E ?
115.77
Dividend yield ?
0.00%
Beta ?
0.60
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
58
Quality
47
Growth
100

Stocklytics score rationale: value 58, quality 47, growth 100.

Financials

2016201720182019202020212022202320242025
18030003110000682900032166000184370009434000007500000

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company operates primarily from its headquarters in Burnaby, Canada. Its robust clinical pipeline showcases several promising candidates: XEN496, an activator of Kv7 potassium channels, is currently in Phase III clinical trials…

Fair value

XENE fair value Not meaningful. Price $36.75.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful. The model is more than 80% below the live price, which happens for unprofitable or very early companies and is not a price target.

Compare XENE

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-02—-1.13—1.33M
2026-08-06-1.11-1.14—1.67M
2026-05-07-1.17-1.17—1.36M
2026-02-26-1.31-1.20—-178.57K
2025-11-03-1.15-1.16——
2025-08-11-1.07-1.03——
2025-05-12-0.83-0.947.50M1.91M
2025-02-27-0.84-0.89—312.50K
2024-11-12-0.81-0.82—294.12K
2024-08-08-0.75-0.72——
2024-05-09-0.62-0.69——
2024-02-29-0.64-0.765.38M1.89M
2023-11-08-0.73-0.75—2.29M
2023-08-09-0.72-0.69—400.00K
2023-05-09-0.63-0.62—570.00K
2023-03-01-0.57-0.588.77K2.91M
2022-11-08-0.57-0.52132.00K4.15M
2022-08-09-0.55-0.49536.00K4.18M
2022-05-10-0.35-0.388.77M7.74M
2022-03-01-0.57-0.473.74M5.69M
2021-11-10-0.36-0.448.12M9.60M
2021-08-11-0.51-0.492.22M2.22M
2021-05-11-0.42-0.454.36M4.46M
2021-03-01-0.34-0.405.15M—
2020-11-05-0.25-0.156.55M5.41M
2020-08-06-0.01-0.2413.38M23.85M
2020-05-21-0.22-0.317.08M10.30M
2020-03-09-0.420.413.33M3.80M
2019-11-05-0.33-0.493.50M5.09M
2019-08-06-0.37-0.46——
2019-05-07-0.42-0.36——
2019-03-06-0.29-0.376.00M—
2018-11-06-0.33-0.47——
2018-08-07-0.45-0.49——
2018-05-08-0.21-0.48——
2018-03-07-0.45-0.1116.00K3.91K
2017-11-07-0.43-0.08264.00K42.98K
2017-08-03-0.41-0.3815.00K14.27K
2017-05-09-0.43-0.3516.00K14.48K
2017-03-08-0.32-0.42376.00K493.50K

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-15Kelly Thomas PatrickBuy7.50K——
2026-10-15Kelly Thomas PatrickSell7.50K——
2026-09-30Kelly Thomas PatrickBuy15.00K$37.32559.74K
2026-09-30MORTIMER IANBuy30.00K$37.381.12M
2026-09-01Svoronos DawnBuy5.14K$8.1541.92K
2026-09-01Svoronos DawnSell5.14K$8.1541.92K
2026-08-28KENNEY CHRISTOPHER JOHNSell6.37K$60.17383.15K
2026-08-28KENNEY CHRISTOPHER JOHNSell700$60.9842.68K
2026-08-11GANNON STEVENSell10.00K$64.06640.55K
2026-06-05PATOU GARYSell1.32K$53.1470.25K
2026-06-05Cannon GillianSell1.19K$53.1463.24K
2026-06-03PATOU GARYBuy10.51K$53.46561.70K
2026-06-03PATOU GARYBuy1.59K——
2026-06-03Machado PatrickBuy10.51K$53.46561.70K
2026-06-03Machado PatrickBuy1.59K——
2026-06-03Gover Justin D.Buy10.51K$53.46561.70K
2026-06-03Gover Justin D.Buy1.59K——
2026-06-03GAROFALO ELIZABETH A.Buy10.51K$53.46561.70K
2026-06-03GAROFALO ELIZABETH A.Buy1.59K——
2026-06-03GANNON STEVENBuy10.51K$53.46561.70K
2026-06-03GANNON STEVENBuy1.59K——
2026-06-03Cannon GillianBuy10.51K$53.46561.70K
2026-06-03Cannon GillianBuy1.59K——
2026-06-03Svoronos DawnBuy10.51K$53.46561.70K
2026-06-03Svoronos DawnBuy1.59K——
2026-06-01PATOU GARYBuy2.65K——
2026-06-01PATOU GARYSell2.65K——
2026-06-01Machado PatrickBuy2.65K——
2026-06-01Machado PatrickSell2.65K——
2026-06-01Gover Justin D.Buy2.65K——
2026-06-01Gover Justin D.Sell2.65K——
2026-06-01GAROFALO ELIZABETH A.Buy2.65K——
2026-06-01GAROFALO ELIZABETH A.Sell2.65K——
2026-06-01GANNON STEVENBuy2.65K——
2026-06-01GANNON STEVENSell1.42K$53.4175.63K
2026-06-01GANNON STEVENSell2.65K——
2026-06-01Cannon GillianBuy2.65K——
2026-06-01Cannon GillianSell2.65K——
2026-06-01Svoronos DawnBuy2.65K——
2026-06-01Svoronos DawnSell1.42K$53.4175.63K
2026-06-01Svoronos DawnSell2.65K——
2026-05-12GANNON STEVENBuy3.50K$7.3825.83K
2026-05-12GANNON STEVENSell3.50K$7.3825.83K
2026-03-13KENNEY CHRISTOPHER JOHNSell1.41K$55.2377.87K
2026-03-13DiFabio AndreaSell1.34K$55.2374.11K
2026-03-13MORTIMER IANSell7.31K$55.23403.58K
2026-03-12KENNEY CHRISTOPHER JOHNSell3.75K——
2026-03-12KENNEY CHRISTOPHER JOHNBuy3.75K——
2026-03-12DiFabio AndreaSell3.75K——
2026-03-12DiFabio AndreaBuy3.75K——
2026-03-12MORTIMER IANSell12.50K——
2026-03-12MORTIMER IANBuy12.50K——
2026-03-10KENNEY CHRISTOPHER JOHNSell2.77K$60.11166.56K
2026-03-10DiFabio AndreaSell2.61K$60.11156.70K
2026-03-10MORTIMER IANSell11.27K$60.11677.36K
2026-03-09KENNEY CHRISTOPHER JOHNBuy7.50K——
2026-03-09KENNEY CHRISTOPHER JOHNBuy7.50K——
2026-03-09KENNEY CHRISTOPHER JOHNSell7.50K——
2026-03-09DiFabio AndreaBuy7.50K——
2026-03-09DiFabio AndreaBuy7.50K——
2026-03-09DiFabio AndreaSell7.50K——
2026-03-09MORTIMER IANBuy105.00K$4.75498.75K
2026-03-09MORTIMER IANBuy75.00K$8.40630.00K
2026-03-09MORTIMER IANSell43.35K$59.262.57M
2026-03-09MORTIMER IANBuy65.00K$9.44613.60K
2026-03-09MORTIMER IANSell21.79K$58.811.28M
2026-03-09MORTIMER IANBuy25.00K$3.1077.50K
2026-03-09MORTIMER IANSell31.69K$59.881.90M
2026-03-09MORTIMER IANBuy20.00K——
2026-03-09MORTIMER IANBuy20.00K——
2026-03-09MORTIMER IANSell12.48K$59.50742.50K
2026-03-09MORTIMER IANSell10.07K$60.47609.05K
2026-03-09MORTIMER IANSell65.00K$62.064.03M
2026-03-09MORTIMER IANSell2.45K$61.26150.03K
2026-03-09MORTIMER IANSell61.65K$60.083.70M
2026-03-09MORTIMER IANSell21.52K$60.491.30M
2026-03-09MORTIMER IANSell25.00K$3.1077.50K
2026-03-09MORTIMER IANSell105.00K$4.75498.75K
2026-03-09MORTIMER IANSell65.00K$9.44613.60K
2026-03-09MORTIMER IANSell75.00K$8.40630.00K
2026-03-09MORTIMER IANSell20.00K——
2026-01-09KENNEY CHRISTOPHER JOHNBuy100.00K$42.154.21M
2026-01-09KENNEY CHRISTOPHER JOHNBuy20.00K——
2026-01-09Cline Darren SBuy40.00K$42.151.69M
2026-01-09Cline Darren SBuy20.00K——
2026-01-09DiFabio AndreaBuy80.00K$42.153.37M
2026-01-09DiFabio AndreaBuy15.00K——
2026-01-09MORTIMER IANBuy350.00K$42.1514.75M
2026-01-09MORTIMER IANBuy65.00K——
2026-01-02MORTIMER IANBuy40.00K$7.49299.60K
2026-01-02MORTIMER IANSell37.94K$44.401.68M
2026-01-02MORTIMER IANSell2.06K$44.9392.65K
2026-01-02MORTIMER IANSell40.00K$7.49299.60K
2025-12-08MORTIMER IANSell8.82K$45.59402.10K
2025-12-08MORTIMER IANSell2.01K$46.3293.10K
2025-12-05MORTIMER IANSell14.38K$45.03647.31K
2025-11-28MORTIMER IANSell97$45.014.37K
2025-10-15Kelly Thomas PatrickBuy225.00K$41.909.43M
2025-10-15Kelly Thomas PatrickBuy30.00K——
2025-10-15Kelly Thomas PatrickOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 325, holders +19 vs prior quarter. Ownership 101.79%.

HolderSharesChangeChange %Value
FMR LLC9.65M-1.17M-10.82%582.35M
BLACKROCK, INC.7.52M1.88M+33.37%454.06M
AVORO CAPITAL ADVISORS LLC5.78M00.00%348.75M
POLAR CAPITAL HOLDINGS PLC4.57M165.24K+3.75%275.88M
DRIEHAUS CAPITAL MANAGEMENT LLC4.42M-73.10K-1.63%266.70M
JUPITER TOPCO LLC4.19M4.19MNew252.67M
PRICE T ROWE ASSOCIATES INC /MD/3.25M1.92M+144.30%196.06M
JPMORGAN CHASE & CO2.62M693.75K+36.07%157.38M
CAPITAL INTERNATIONAL INVESTORS2.36M-313.09K-11.71%142.55M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.2.17M1.22M+127.80%130.90M
STATE STREET CORP1.97M249.10K+14.48%118.89M
TWO SIGMA INVESTMENTS, LP1.64M1.04M+171.06%99.16M
DEERFIELD MANAGEMENT COMPANY, L.P.1.62M00.00%97.52M
AFFINITY ASSET ADVISORS, LLC1.59M-80.00K-4.78%96.27M
WESTFIELD CAPITAL MANAGEMENT CO LP1.51M105.81K+7.55%90.98M
ALLIANCEBERNSTEIN L.P.1.56M158.98K+11.33%90.85M
FRANKLIN TEMPLETON INC1.44M157.13K+12.27%86.78M
WELLINGTON MANAGEMENT GROUP LLP1.43M-3.40M-70.48%86.04M
CITADEL ADVISORS LLC1.40M-1.25M-47.18%84.58M
GEODE CAPITAL MANAGEMENT, LLC1.37M277.18K+25.36%82.69M
SIREN, L.L.C.1.32M00.00%79.59M
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A.1.29M-51.30K-3.82%77.91M
PICTET ASSET MANAGEMENT HOLDING SA1.19M508.01K+74.74%71.65M
BRAIDWELL LP1.13M-207.00K-15.47%68.29M
NUVEEN, LLC993.13K743.09K+297.19%59.95M

Forecast

Consensus Buy from 19 analysts. Average price target $68.63, +86.7% versus the current price. Low $46.00. High $90.00.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Analysts have an average 12-month price target of $68.63 for Xenon Pharmaceuticals (XENE), 87.1% above the current price of $36.68. Of 19 analysts covering the stock, 18 rate it Buy or Strong Buy, 1 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.

Forecasts are third-party estimates and often wrong. They are not investment advice.

XENE price target

12-month price target
Low$46.00
Average$68.63
High$90.00

The average is 87.1% above the current price of $36.68.

Is Xenon Pharmaceuticals a buy or sell?

Of 19 analysts, 18 rate Xenon Pharmaceuticals Buy or Strong Buy, 1 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.

Xenon Pharmaceuticals earnings and revenue forecast

Analyst averages on file: 2026, EPS -4.61, revenue $1.34 million. 2027, EPS -4.69, revenue $26.98 million.

XENE score and fair value

The Stocklytics Score for XENE is 68 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.

XENE forecast FAQs

What is the XENE price target?

$68.63 average, with a published range of $46.00 to $90.00.

Is Xenon Pharmaceuticals a buy or sell?

The consensus is Buy from 19 analysts. This is not a recommendation.

What is the Xenon Pharmaceuticals stock forecast for 2026?

Analysts' average EPS estimate for 2026 on file is -4.61. The average revenue estimate is $1.34 million.

What will XENE be worth in 2030?

No reliable forecast exists that far out.

When is Xenon Pharmaceuticals's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Related: Xenon Pharmaceuticals · Financials · Dividends · Compare · AI stocks

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

Xenon Pharmaceuticals (XENE) Stock Forecast & Price Target

XENE$36.75+0.41 +1.13%

$3.56B

Market Cap

-7.67

P/E

115.77

Forward P/E

68

Score

Price History